The search textbox has an autosuggest feature. When you enter three or more characters,
a list of up to 10 suggestions will popup under the textbox. Use the arrow keys
to move through the suggestions. To select a suggestion, hit the enter key. Using
the escape key closes the listbox and puts you back at the textbox. The radio buttons
allow you to toggle between having all search items start with or contain the text
you entered in the search box.
buserelin
A synthetic analog of gonadotropin-releasing hormone (GnRH). Buserelin binds to and activates pituitary gonadotropin releasing hormone (GnRH) receptors. Prolonged administration of buserelin results in sustained inhibition of gonadotropin production, suppression of testicular and ovarian steroidogenesis, and reduced levels of circulating gonadotropin and gonadal steroids. Buserelin is more potent that GnRH. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| Synonyms: | | buserelin acetate busereline | |
| |||
| US brand name: | | Etilamide | |
| |||
| Foreign brand names: | | Bigonist Profact Profact Depot Receptal Suprecur Suprefact Suprefact Depot Suprefact Flakon | |
| |||
| Abbreviation: | | BSRL | |
| |||
| Code names: | | HOE 766 ICI 123215 S74-6766 | |
| |||
| Chemical structures: | | 6-[O-(1,1-dimethylethyl)-D-serine]-9-(N-ethyl-L-prolinamide)-10-deglycinamide luteinizing hormone-releasing factor (pig) D-ser (bu(t))(6) pro(9) NEt LHRH Acetate | |
| |||
